Literature DB >> 10170706

Benign moral hazard and the cost-effectiveness analysis of insurance coverage.

M V Pauly1, P J Held.   

Abstract

When a medical intervention is found to be cost effective, what level of insurance coverage should apply to it? The optimal level of coverage may be less than or greater than full coverage of medical care costs; a finding of cost effectiveness for a service does not necessarily imply v full coverage or coverage at the same rate as other services. If there is some imperfection in the ability to translate higher insurance benefits into higher insurer revenues, the optimal level of coverage will be greater the higher the degree of moral hazard applying to the service.

Mesh:

Year:  1990        PMID: 10170706     DOI: 10.1016/0167-6296(90)90005-n

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  8 in total

1.  A game-theoretic framework for estimating a health purchaser's willingness-to-pay for health and for expansion.

Authors:  Reza Yaesoubi; Stephen D Roberts
Journal:  Health Care Manag Sci       Date:  2010-08-12

2.  Should Medicaid include adult coverage for preventive dental procedures? What evidence is needed?

Authors:  Shulamite S Huang
Journal:  J Am Dent Assoc       Date:  2020-08       Impact factor: 3.634

3.  Severity of illness and the welfare effects of moral hazard.

Authors:  Joseph G Eisenhauer
Journal:  Int J Health Care Finance Econ       Date:  2006-11-30

Review 4.  End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF).

Authors:  Avi Dor; Mark V Pauly; Margaret A Eichleay; Philip J Held
Journal:  Int J Health Care Finance Econ       Date:  2007-09

5.  Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care.

Authors:  Anirban Basu
Journal:  J Health Econ       Date:  2011-04-23       Impact factor: 3.883

6.  A randomized controlled trial of co-payment elimination: the CHORD trial.

Authors:  Kevin G Volpp; Andrea B Troxel; Judith A Long; Said A Ibrahim; Dina Appleby; J Otis Smith; Jane Jaskowiak; Marie Helweg-Larsen; Jalpa A Doshi; Stephen E Kimmel
Journal:  Am J Manag Care       Date:  2015-08       Impact factor: 2.229

7.  Financial Incentives to Improve Colorectal Cancer Screening-Time to Cut Our Losses.

Authors:  Rachel B Issaka; Jason A Dominitz
Journal:  JAMA Netw Open       Date:  2021-08-02

8.  Choosing wisely: low-value services, utilization, and patient cost sharing.

Authors:  Kevin G Volpp; George Loewenstein; David A Asch
Journal:  JAMA       Date:  2012-10-24       Impact factor: 56.272

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.